New Pharmaceutical Warnings Placed on Proton Pump Inhibitors (PPIs) Greetings! This month’s Pharmaceutical Alert highlights the ongoing problems with PPIs, the Proton Pump Inhibitors. We wrote to you about the problems with these drugs more than a year ago, and finally the FDA is taking action, issuing a Warning Alert. We hope you will read…